EJNMMI Research
ISSN: 2191-219X
Publisher: SpringerOpen / BioMed Central
Publications (13)
Dosimetric analysis reveals rapid clearance and low absorbed dose of [¹⁷⁷Lu]Lu-PSMA-617 in non-prostate cancers with high PSMA expression (2026)
Khreish F, Rosar F, Burgard C, Petto S, Maus S, Stemler T, Bartholomä M, et al.
Journal article
Outcome and safety of single-dose docetaxel–augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience (2026)
Ebert N, Rosar F, Burgard C, Bartholomä M, Maus S, Hein C, Blickle A, et al.
Journal article
Quantitative terbium-161 SPECT/CT imaging: demonstrating the feasibility of image-based dosimetry and highlighting pitfalls (2025)
Westerbergh F, van der Meulen NP, Müller C, Grings A, Ritt P, Bernhardt P
Journal article
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma (2025)
Beck M, Blumenberg V, Bücklein VL, Bundschuh RA, Harrer DC, Hirschbühl K, Jung J, et al.
Journal article
Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia (2025)
Bastian MB, Speicher T, Blickle A, Burgard C, Bastian JL, Bartholomä M, Schaefer-Schuler A, et al.
Journal article
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation (2024)
Bolik KV, Hellmann J, Maschauer S, Neu E, Einsiedel J, Riss P, Vogg N, et al.
Journal article
CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett’s esophagus (2022)
Marcazzan S, Carvalho MJB, Konrad M, Strangmann J, Tenditnaya A, Baumeister T, Schmid RM, et al.
Journal article
[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma (2021)
Harder FN, Jungmann F, Kaissis GA, Lohoefer FK, Ziegelmayer S, Havel D, Quante M, et al.
Journal article
Neuron-specific enolase has potential value as a biomarker for [18F]FDG/[68Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients (2020)
Rosar F, Ribbat K, Ries M, Linxweiler J, Bartholomä M, Maus S, Schreckenberger M, et al.
Journal article
Whole tumor kinetics analysis of 18F-fluoromisonidazole dynamic PET scans of non-small cell lung cancer patients, and correlations with perfusion CT blood flow (2018)
Mcgowan DR, Skwarski M, Papiez BW, Macpherson RE, Gleeson FV, Schnabel JA, Higgins GS, Fenwick JD
Journal article